Insider Transactions in Q4 2024 at Castle Biosciences Inc (CSTL)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
9,364
-4.98%
|
$262,192
$28.55 P/Share
|
|
Dec 16
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
11,059
-10.51%
|
$309,652
$28.83 P/Share
|
|
Dec 13
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
1,579
-0.98%
|
$44,212
$28.82 P/Share
|
|
Dec 13
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
13,485
-5.81%
|
$377,580
$28.82 P/Share
|
|
Dec 10
2024
|
Tobin W Juvenal Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,998
-1.38%
|
$57,942
$29.63 P/Share
|
|
Dec 10
2024
|
Tobin W Juvenal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,919
+5.12%
|
-
|
|
Dec 10
2024
|
Kristen M Oelschlager Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,156
-0.71%
|
$62,524
$29.63 P/Share
|
|
Dec 10
2024
|
Kristen M Oelschlager Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,919
+2.51%
|
-
|
|
Dec 10
2024
|
Frank Stokes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,673
-4.11%
|
$106,517
$29.63 P/Share
|
|
Dec 10
2024
|
Frank Stokes Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,169
+8.23%
|
-
|
|
Dec 10
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,180
-3.38%
|
$237,220
$29.63 P/Share
|
|
Dec 10
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,787
+7.8%
|
-
|
|
Dec 09
2024
|
Tobin W Juvenal Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,887
-5.54%
|
$116,610
$30.91 P/Share
|
|
Dec 09
2024
|
Tobin W Juvenal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,961
+18.54%
|
-
|
|
Dec 09
2024
|
Kristen M Oelschlager Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,206
-2.79%
|
$126,180
$30.91 P/Share
|
|
Dec 09
2024
|
Kristen M Oelschlager Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,961
+9.56%
|
-
|
|
Dec 09
2024
|
Frank Stokes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,571
-14.46%
|
$197,130
$30.91 P/Share
|
|
Dec 09
2024
|
Frank Stokes Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,617
+24.34%
|
-
|
|
Dec 09
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,181
-11.05%
|
$395,430
$30.91 P/Share
|
|
Dec 09
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,496
+21.93%
|
-
|
|
Dec 05
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
3,155
-3.72%
|
$97,805
$31.35 P/Share
|
|
Dec 05
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
1,972
-2.25%
|
$61,132
$31.35 P/Share
|
|
Dec 03
2024
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,867
-17.19%
|
$243,877
$31.14 P/Share
|
|
Nov 15
2024
|
Frank Stokes Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,923
-9.38%
|
$207,690
$30.14 P/Share
|
|
Nov 12
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
3,155
-3.56%
|
$107,270
$34.15 P/Share
|
|
Nov 12
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
1,972
-2.2%
|
$67,048
$34.15 P/Share
|
|
Nov 05
2024
|
Tobin W Juvenal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,507
-6.08%
|
$122,745
$35.56 P/Share
|
|
Nov 05
2024
|
Tobin W Juvenal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,507
+5.73%
|
$10,521
$3.38 P/Share
|
|
Nov 04
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
3,155
-1.71%
|
$100,960
$32.84 P/Share
|
|
Nov 04
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
1,972
-1.08%
|
$63,104
$32.84 P/Share
|
|
Nov 01
2024
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,867
-9.07%
|
$267,478
$34.72 P/Share
|
|
Nov 01
2024
|
Tobin W Juvenal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,100
-5.41%
|
$108,500
$35.39 P/Share
|
|
Nov 01
2024
|
Tobin W Juvenal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+1.88%
|
$3,300
$3.38 P/Share
|
|
Oct 14
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
3,155
-3.28%
|
$100,960
$32.27 P/Share
|
|
Oct 14
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
1,972
-2.11%
|
$63,104
$32.27 P/Share
|
|
Oct 08
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
1,576
-1.61%
|
$47,280
$30.27 P/Share
|
|
Oct 08
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
986
-1.04%
|
$29,580
$30.27 P/Share
|
|
Oct 07
2024
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,867
-20.0%
|
$228,143
$29.44 P/Share
|
|
Oct 04
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
1,579
-1.58%
|
$44,212
$28.73 P/Share
|
|
Oct 04
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
986
-1.03%
|
$27,608
$28.73 P/Share
|